Insulin-like growth factor (IGF)-I is a ubiquitous peptide hormone involved in a host of critical physiological processes (e.g., protein synthesis and glucose homeostasis) and has been suggested to be a biomarker reflecting health and metabolic status. In most cases (muscle, bone, tendon, body composition, and cognitive function), elevated IGF-I concentrations are considered beneficial; however, cancer remains a notable exception. While the fact that both increased and decreased IGF-I can be considered reflective of favorable and beneficial health outcomes may appear as a paradox, it is important to emphasize that, in both cases, measured IGF-I concentrations do offer important insight into physiological processes. The effects of military operational field training on the circulating IGF-I system are discussed within the context of novel measurement technologies that (1) are field expedient and (2) provide more meaningful information. Prospective experimental approaches involving physical activity that sample and measure IGF-I in the body's various biocompartments will provide greater insight into the complex role that IGF-I possesses. Minimally invasive technologies that are field expedient, cost-effective, and allow for continuous and real-time feedback will have the greatest likelihood of being adapted and used in military environments.
AdamsGR. Role of insulin-like growth factor-I in the regulation of skeletal muscle adaptation to increased loading. Exerc Sport Sci Rev.1998;26: 31–60.
JonesJIClemmonsDR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev.1995;16 (1): 3–34.
4.
RajaramSBaylinkDJMohanS. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endoc Rev.1997;18 (6): 801–31.
5.
FriedlKE. Insulin-like growth factor-I: a metabolic marker representing quality of life?. Diabetes Technol Ther.2003;5 (3): 463–5.
6.
NindlBCPierceJR. Insulin-like growth factor-I as a biomarker of health, fitness and training status. Med Sci Sports Exerc. (In Review).
7.
BrugtsMPvan den BeldAWHoflandLJvan der WansemKvan KoetsveldPMFrystykJLambertsSWJanssenJA. Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality. J Clin Endocrinol Metab.2008;93 (7): 2515–22.
8.
NindlBCAlemanyJAKelloggMDRoodJAllisonSAYoungAJMontainSJ. Utility of circulating IGF-I as a biomarker for assessing body composition changes in men during periods of high physical activity superimposed upon energy and sleep restriction. J Appl Physiol.2007;103 (1): 340–6.
9.
NindlBCScovilleCRSheehanKMLeoneCDMelloRP. Gender differences in regional body composition and somatotrophic influences of IGF-I and leptin. J Appl Physiol.2002;92 (4): 1611–8.
10.
OngKKratzschJKiessWDungerD, ALSPAC Study Team. Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab.2002;87 (3): 1041–4.
11.
PoehlmanETCopelandKC. Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. J Clin Endocrinol Metab.1990;71 (6): 1468–73.
12.
AndreassenMRaymondIKistorpCHildebrandtPFaberJKristensenLØ. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. Eur J Endocrinol.2008;160 (1): 25–31.
13.
RenehanAGZwahlenMMinderCO'DwyerSTShaletSMEggerM. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet.2004;363 (9418): 1346–53.
14.
ShimokawaIHigamiYUtsuyamaMTuchiyaTKomatsuTChibaTYamazaH. Life span extension by reduction in growth hormone-insulin-like growth factor-1 axis in a transgenic rat model. Am J Pathology.2002;160 (6): 2259–65.
15.
RajpathakSNGunterMJWylie-RosettJHoGYKaplanRCMuzumdarRRohanTEStricklerHD. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev.2009;25 (1): 3–12.
16.
RarickKRPikoskyMAGrediaginASmithTJGlickmanELAlemanyJAStaabJSYoungAJNindlBC. Energy flux, more so than energy balance, protein intake, or fitness level, influences insulin-like growth factor-I system responses during 7 days of increased physical activity. J Appl Physiol.2007;103 (5): 1613–21.
17.
RosendalLLangbergHFlyvbjergAFrystykJØrskovHKjaerM. Physical capacity influences the response of insulin-like growth factor and its binding proteins to training. J Appl Physiol.2002;93 (5): 1669–75.
18.
FriedlKEMooreRJHoytRWMarchitelliLJMartinez-LopezLEAskewEW. Endocrine markers of semistarvation in healthy lean men in a multistressor environment. J Appl Physiol.2000;88 (5): 1820–30.
19.
NindlBCCastellaniJWYoungAJPattonJFKhosraviMJDiamandiAMontainSJ. Differential responses of IGF-I molecular complexes to military operational field training. J Appl Physiol.2003;95 (3): 1083–9.
20.
NindlBCKelloggMDKhosraviMJDiamandiAAlemanyJAPietilaDMYoungAJMontainSJ. Measurement of insulin-like growth factor-I during military operational stress via a filter paper blood spot assay. Diabetes Technol Ther.2003;5 (3): 455–61.
21.
NindlBCKraemerWJMarxJOArcieroPJDohiKKelloggMDLoomisGA. Overnight responses of the circulating IGF-I system after acute, heavy-resistance exercise. J Appl Physiol.2001;90 (4): 1319–26.
22.
AlemanyJANindlBCKelloggMDTharionWJYoungAJMontainSJ. Effects of dietary protein content on IGF-I, testosterone, and body composition during 8 days of severe energy deficit and arduous physical activity. J Appl Physiol.2008;105 (1): 58–64.
23.
FriedlKEMooreRJMartinez-LopezLEVogelJAAskewEWMarchitelliLJHoytRWGordonCC. Lower limit of body fat in healthy active men. J Appl Physiol.1994;77 (2): 933–40.
24.
NindlBCFriedlKEFrykmanPNMarchitelliLJShippeeRLPattonJF. Physical performance and metabolic recovery among lean, healthy men following a prolonged energy deficit. Int J Sports Med.1997;18 (5): 317–24.
25.
NindlBCLeoneCDTharionWJJohnsonRFCastellaniJWPattonJFMontainSJ. Physical performance responses during 72 h of military operational stress. Med Sci Sports Exerc.2002;34 (11): 1814–22.
26.
DiamandiAKhosraviMJMistryJMartinezVGuevara-AguirreJ. Filter paper blood spot assay of human insulin-like growth factor I (IGF-I) and IGF-binding protein-3 and preliminary application in the evaluation of growth hormone status. J Clin Endocrinol Metab.1998;83 (7): 2296–301.
27.
NindlBCTuckowAPAlemanyJAHarmanEARarickKRStaabJSFaupelMLKhosraviMJ. Minimally invasive sampling of transdermal body fluid for the purpose of measuring insulin-like growth factor-I during exercise training. Diabetes Technol Ther.2006;8 (2): 244–52.
28.
BergUGustafssonTSundbergCJKaijserLCarlsson-SkwirutCBangP. Interstitial IGF-I in exercising skeletal muscle in women. Eur J Endocrinol.2007;157 (4): 427–35.
29.
HansenMKoskinenSOPetersenSGDoessingSFrystykJFlyvbjergAWesthEMagnussonSPKjaerMLangbergH. Ethinyl oestradiol administration in women suppresses synthesis of collagen in tendon in response to exercise. J Physiol.2008;586 (Pt 12): 3005–16.
30.
HansenMMillerBFHolmLDoessingSPetersenSGSkovgaardDFrystykJFlyvbjergAKoskinenSPingelJKjaerMLangbergH. Effect of administration of oral contraceptives in vivo on collagen synthesis in tendon and muscle connective tissue in young women. J Appl Physiol.2008. [Epub ahead of print.].
31.
ChenJWLedetTOrskovHJessenNLundSWhittakerJDe MeytsPLarsenMBChristiansenJSFrystykJ. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab.2003;284 (6): E1149–55.
